As of 2025-07-01, the Relative Valuation of Novavax Inc (NVAX) is 63.17 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.30 USD, the upside of Novavax Inc based on Relative Valuation is 902.7%.
The range of the Relative Valuation is 46.70 - 72.94 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.4x - 23.6x | 21.2x |
| Forward P/E multiples | 15.8x - 24.7x | 21.5x |
| Fair Price | 46.70 - 72.94 | 63.17 |
| Upside | 641.2% - 1057.8% | 902.7% |
| Date | P/E |
| 2025-07-01 | 2.22 |
| 2025-06-30 | 2.13 |
| 2025-06-27 | 2.16 |
| 2025-06-26 | 2.20 |
| 2025-06-25 | 2.19 |
| 2025-06-24 | 2.20 |
| 2025-06-23 | 2.14 |
| 2025-06-20 | 2.17 |
| 2025-06-18 | 2.13 |
| 2025-06-17 | 2.20 |
| 2025-06-16 | 2.38 |
| 2025-06-13 | 2.35 |
| 2025-06-12 | 2.42 |
| 2025-06-11 | 2.40 |
| 2025-06-10 | 2.44 |
| 2025-06-09 | 2.51 |
| 2025-06-06 | 2.52 |
| 2025-06-05 | 2.37 |
| 2025-06-04 | 2.42 |
| 2025-06-03 | 2.46 |
| 2025-06-02 | 2.39 |
| 2025-05-30 | 2.48 |
| 2025-05-29 | 2.43 |
| 2025-05-28 | 2.34 |
| 2025-05-27 | 2.50 |
| 2025-05-23 | 2.45 |
| 2025-05-22 | 2.47 |
| 2025-05-21 | 2.41 |
| 2025-05-20 | 2.60 |
| 2025-05-19 | 2.62 |
| 2025-05-16 | 2.28 |
| 2025-05-15 | 2.13 |
| 2025-05-14 | 2.02 |
| 2025-05-13 | 2.09 |
| 2025-05-12 | 2.15 |
| 2025-05-09 | 2.02 |
| 2025-05-08 | 2.25 |
| 2025-05-07 | 2.01 |
| 2025-05-06 | 2.05 |
| 2025-05-05 | 2.12 |
| 2025-05-02 | 2.17 |
| 2025-05-01 | 2.17 |
| 2025-04-30 | 2.26 |
| 2025-04-29 | 2.17 |
| 2025-04-28 | 2.27 |
| 2025-04-25 | 2.26 |
| 2025-04-24 | 2.39 |
| 2025-04-23 | 2.53 |
| 2025-04-22 | 2.11 |
| 2025-04-21 | 2.03 |